Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance
{{output}}
Cetuximab and panitumumab, as the highly effective antibodies targeting epidermal growth factor receptor (EGFR), have clinical activity in the patients with metastatic colorectal cancer (mCRC). These agents have good curative efficacy, but drug resistance also... ...
